146 related articles for article (PubMed ID: 19461082)
1. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
Renshaw AA; Deschênes M; Auger M
Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
[TBL] [Abstract][Full Text] [Related]
2. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
[TBL] [Abstract][Full Text] [Related]
3. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
[No Abstract] [Full Text] [Related]
4. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the Bethesda System 2001 to a public health setting.
Prandi S; Beccati D; De Aloysio G; Fulgenzi P; Gabrielli M; Ghirardini C; Rivasi F; Saragoni L; de Bianchi PS; Bucchi L
Cancer; 2006 Oct; 108(5):271-6. PubMed ID: 16948127
[TBL] [Abstract][Full Text] [Related]
6. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
7. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
Deschenes M; Renshaw AA; Auger M
Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
[TBL] [Abstract][Full Text] [Related]
8. Quality control in cytopathology applied to screening for cervical carcinoma.
Marsan C
Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
[TBL] [Abstract][Full Text] [Related]
9. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
Djemli A; Khetani K; Case BW; Auger M
Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
[TBL] [Abstract][Full Text] [Related]
12. The ASC/SIL ratio for cytopathologists as a quality control measure: a follow-up study.
Nascimento AF; Cibas ES
Am J Clin Pathol; 2007 Oct; 128(4):653-6. PubMed ID: 17875518
[TBL] [Abstract][Full Text] [Related]
13. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
14. Quality control in Papanicolaou tests.
Wachtel M
Am J Clin Pathol; 2002 Nov; 118(5):804; author reply 805. PubMed ID: 12428803
[No Abstract] [Full Text] [Related]
15. Quality assurance in cervical cytopathology.
Light AM
Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
[No Abstract] [Full Text] [Related]
16. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
Stanley MW
Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
[TBL] [Abstract][Full Text] [Related]
17. Education and training for cytopathologists. Its role in quality assurance.
Parker JE
Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
[TBL] [Abstract][Full Text] [Related]
18. State of the Art Symposium: prescreening and rescreening.
O'Leary TJ
Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
[TBL] [Abstract][Full Text] [Related]
19. Cytopathology in France.
Cochand-Priollet B; Vincent S; Vielh P
Cytopathology; 2004 Jun; 15(3):163-6. PubMed ID: 15165274
[TBL] [Abstract][Full Text] [Related]
20. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
